Health Research Board. (2025) Drug use prevalence in Ireland: findings from recent population studies and estimates of problematic use. Issue 92, Autumn 2025, Supplement pp. 1-20. Dublin: Health Research Board.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Drugnet Ireland issue 92 - supplement - Drug use prevalence in Ireland)
970kB |
In this supplement
P.2 New estimates of problematic opioid use in Ireland, 2020–2022
P.8 Results from the 2023 Healthy Ireland Survey on drug use in Ireland
P.13 Substance use among Irish 15–16-year-olds: new findings from European School Survey Project on Alcohol and Other Drugs, 2024
P.16 Drug use among 25–year-olds in Ireland: results from the GUI study
P.17 Cannabis use findings from the Health Behaviour in School-aged Children study, 2022
P.19 Cannabis use among Irish adolescents: risk and protective factors
B Substances > Cannabis / Marijuana
B Substances > Substances in general
B Substances > Hallucinogens / Psychedelics > LSD (Lysergic acid diethylamide)
B Substances > Hallucinogens / Psychedelics > Mushrooms (psilocybin / Amanita muscaria /Psilocybe)
B Substances > Inhalants and solvents
B Substances > Inhalants and solvents > Nitrous oxide (laughing gas)
B Substances > CNS stimulants > Amphetamines
B Substances > CNS stimulants > MDMA / Ecstasy
B Substances > Cocaine
B Substances > Cocaine > Crack cocaine
B Substances > Opioids (opiates)
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines > Ketamine
G Health and disease > Substance use disorder (addiction) > Drug use disorder
J Health care, prevention, harm reduction and treatment > Risk and protective factors
T Demographic characteristics > Adolescent / youth (teenager / young person)
T Demographic characteristics > Young adult
T Demographic characteristics > Gender / sex differences
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page